92 related articles for article (PubMed ID: 28765903)
1. Wild-type p53 controls the level of fibronectin expression in breast cancer cells.
You D; Jung SP; Jeong Y; Bae SY; Kim S
Oncol Rep; 2017 Oct; 38(4):2551-2557. PubMed ID: 28765903
[TBL] [Abstract][Full Text] [Related]
2. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
3. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells.
Kim S; Oh SJ; Lee J; Han J; Jeon M; Jung T; Lee SK; Bae SY; Kim J; Gil WH; Kim SW; Lee JE; Nam SJ
Cell Physiol Biochem; 2013; 32(5):1541-50. PubMed ID: 24335179
[TBL] [Abstract][Full Text] [Related]
4. Effect of berberine on p53 expression by TPA in breast cancer cells.
Kim S; Han J; Kim NY; Lee SK; Cho DH; Choi MY; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE
Oncol Rep; 2012 Jan; 27(1):210-5. PubMed ID: 21964832
[TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
Oh SJ; Jung SP; Han J; Kim S; Kim JS; Nam SJ; Lee JE; Kim JH
Oncol Rep; 2013 Apr; 29(4):1343-8. PubMed ID: 23353996
[TBL] [Abstract][Full Text] [Related]
6. Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells.
Jeon M; Lee J; Nam SJ; Shin I; Lee JE; Kim S
Exp Cell Res; 2015 Apr; 333(1):116-26. PubMed ID: 25743092
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression of HER2/neu downregulates wild p53 protein expression via PI3K and Ras/Raf/MEK/ERK pathways in human breast cancer cells].
Zheng L; Ren JQ; Zhang L; Chen Q; Zhu HG
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):358-62. PubMed ID: 15363324
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells.
You D; Jung SP; Jeong Y; Bae SY; Lee JE; Kim S
BMB Rep; 2017 Dec; 50(12):615-620. PubMed ID: 28855026
[TBL] [Abstract][Full Text] [Related]
9. Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells.
Kim S; Kim SH; Hur SM; Lee SK; Kim WW; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH
J Ethnopharmacol; 2009 Nov; 126(2):252-7. PubMed ID: 19715751
[TBL] [Abstract][Full Text] [Related]
10. Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells.
Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Kim JS; Kim JH; Choe JH; Yang JH; Nam SJ; Lee JE
Phytomedicine; 2009 Jun; 16(6-7):573-80. PubMed ID: 19181503
[TBL] [Abstract][Full Text] [Related]
11. Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
Hur J; Bell DW; Dean KL; Coser KR; Hilario PC; Okimoto RA; Tobey EM; Smith SL; Isselbacher KJ; Shioda T
Cancer Res; 2006 Oct; 66(20):10153-61. PubMed ID: 17047080
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells.
Vaidya A; Wang H; Qian V; Gilmore H; Lu ZR
Cells; 2020 Aug; 9(8):. PubMed ID: 32756405
[TBL] [Abstract][Full Text] [Related]
13. Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
Li W; Liu Z; Zhao C; Zhai L
Oncol Rep; 2015 Sep; 34(3):1345-52. PubMed ID: 26134759
[TBL] [Abstract][Full Text] [Related]
14. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis in breast cancer cells by TPA.
Li Y; Bhuiyan M; Mohammad RM; Sarkar FH
Oncogene; 1998 Dec; 17(22):2915-20. PubMed ID: 9879997
[TBL] [Abstract][Full Text] [Related]
16. Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms. Role for p53-independent induction of gadd-45 in initiating death.
de Vente JE; Kukoly CA; Bryant WO; Posekany KJ; Chen J; Fletcher DJ; Parker PJ; Pettit GJ; Lozano G; Cook PP
J Clin Invest; 1995 Oct; 96(4):1874-86. PubMed ID: 7560079
[TBL] [Abstract][Full Text] [Related]
17. The role of p53-microRNA 200-Moesin axis in invasion and drug resistance of breast cancer cells.
Alam F; Mezhal F; El Hasasna H; Nair VA; Aravind SR; Saber Ayad M; El-Serafi A; Abdel-Rahman WM
Tumour Biol; 2017 Sep; 39(9):1010428317714634. PubMed ID: 28933253
[TBL] [Abstract][Full Text] [Related]
18. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells.
Kim S; Lee HS; Lee SK; Kim SH; Hur SM; Kim JS; Kim JH; Choe JH; Shin I; Yang JH; Lee JE; Nam SJ
Phytomedicine; 2010 Dec; 17(14):1127-32. PubMed ID: 20554189
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein.
Iotsova V; Stehelin D
Cell Growth Differ; 1996 May; 7(5):629-34. PubMed ID: 8732672
[TBL] [Abstract][Full Text] [Related]
20. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]